Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By

175 Results

  • Includes a Live Web Event on 07/18/2024 at 11:00 AM (PDT)

    Attendees will learn how one organization was able to leverage organizational initiatives to drive meaningful change.

    Description: 

    Date: July 18, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    In anticipation of Sepsis Awareness Month in September, this presentation will showcase innovative strategies for promoting sepsis awareness, quality improvement, and patient safety within healthcare teams during Sepsis Awareness Month and year-round. Attendees will learn how one organization was able to leverage organizational initiatives to drive meaningful change. Through unique and engaging awareness and advocacy efforts that promoted collaboration with key stakeholders and leaned into the power of community partnerships to coordinate inter-disciplinary efforts, this team built a successful advocacy campaign.

    Utilizing available resources to plan and execute impactful sepsis awareness events that promote continuous improvement and patient safety will also be shared. Whether you’re a healthcare professional, administrator, or advocate, this presentation will equip you with the knowledge and tools needed to make a difference during Sepsis Awareness Month and in the fight against sepsis year-round. Get started now with Sepsis Alliance's Sepsis Awareness Month resources at SepsisAwarenessMonth.org.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • List organizational initiatives that can be used to promote sepsis awareness, quality improvement, and patient safety in a healthcare team;
    • Identify ways to collaborate with key stakeholders in healthcare advocacy events;
    • Describe how to use available resources to plan a successful sepsis advocacy and awareness event that promotes continuous improvement.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors. 

          

    image
    image

    Michelle Evans, MSN, RN, APRN, NP-C

    APP Sepsis Program Coordinator

    Summa Health

    Michelle Evans, MSN, RN, APRN, NP-C, obtained her ADN in 1999 and BSN in 2007, both from Walsh University. She earned her Masters as an Advanced Practice Nurse in 2010 from Malone University and is board-certified through the ANCC as a Family Nurse Practitioner. Her clinical background is in Critical Care/Rapid Response and Hospitalist Medicine. Michelle discovered her passion for sepsis care while serving as the Intensivist Program Coordinator for Aultman Hospital from 2002-2009. She has been the Sepsis Program Coordinator for Summa Health System in Akron since January 2021. Michelle resides in Canton, Ohio, with her husband Dave, and has three adult sons. 

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Includes a Live Web Event on 05/30/2024 at 11:00 AM (PDT)

    Content provided by bioMérieux (No CE credits offered)

    Webinar Description: 

    This sponsored webinar will explore the history of Antimicrobial Susceptibility Testing (AST) and what the future of patient care and antimicrobial stewardship could look like with fast AST. The presenter will discuss the limitations of traditional AST methods, which often lead to delays, the overuse of broad-spectrum antibiotics, and the rise of antimicrobial resistance. He will then highlight how fast AST and rapid diagnostics can empower stewardship efforts by providing actionable results within hours.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by bioMérieux for this sponsored webinar.

    image


    Jeffrey J. Cies, PharmD, MPH, BCPS-AQ ID, BCPPS, FCCP, FCCM, FPPA

    Senior Medical Science Liaison

    bioMérieux

    Jeffrey J. Cies, PharmD, MPH, BCPS-AQ ID, BCPPS, FCCP, FCCM, FPPA, is a pediatric critical care and infectious diseases pharmacist with almost two decades of experience, both at the bedside and conducting clinical research in pediatric pharmacotherapy and pharmacokinetics.  His research focused on describing the pharmacokinetic and pharmacodynamic changes in the pediatric ICU with a special focus on extra-corporeal therapies. Dr. Cies now serves as a senior medical science liaison for bioMerieux.

  • Includes a Live Web Event on 05/16/2024 at 9:00 AM (PDT)

    This live, virtual event, scheduled for May 16, 2024, will cover critical topics related to sepsis in maternal and neonatal patients, offering attendees the most up-to-date clinical knowledge and treatment recommendations for these populations.

    Description: 

    Date: May 16, 2024

    Time: 12:00 - 4:00 pm ET / 9:00 am - 1:00 pm PT

    Sepsis, an indiscriminate threat that can strike anyone regardless of their health status or age, tends to disproportionately affect certain populations. Pregnant individuals and newborns are among those at higher risk of sepsis-related complications. Sepsis accounts for at least 261,000 maternal deaths each year worldwide, accounting for approximately 11% of all maternal deaths. Across the U.S. between 2017-2019, 14.3% of pregnancy-related deaths were due to infection or sepsis. Maternal sepsis ranks as the second leading cause of maternal fatalities, and globally sepsis is the number one cause of mortality in newborns and young infants.

    Maternal sepsis typically occurs when an infection takes hold in the aftermath of childbirth, whether it be at the site of a C-section incision, a tear, or another postpartum wound, occurring in the days or weeks following delivery. Any infection, such as Strep B, pneumonia, or a urinary tract infection, occurring during pregnancy or in the postpartum period, can also potentially escalate into sepsis. Infections can be passed from the birthing parent to child during pregnancy, labor, and delivery, putting the infant also at risk for developing sepsis.

    It is imperative that healthcare professionals understand the unique risks that maternal and neonatal patients have regarding sepsis to efficiently and accurately assess and diagnose sepsis.

    To address this issue, Sepsis Alliance is hosting the 2024 Sepsis Alliance Symposium: Maternal and Neonatal Sepsis. This live, virtual event, scheduled for May 16, 2024, will cover critical topics related to sepsis in maternal and neonatal patients, offering attendees the most up-to-date clinical knowledge and treatment recommendations for these populations. The key outcome of this half-day event is to establish the burden of sepsis in maternal and neonatal patients and improve clinical outcomes for patients affected by sepsis.

    Covered topics will include:

    • Perinatal outcomes in patients with sepsis during pregnancy;
    • Improving maternal equity, health outcomes related to infections and sepsis, and antimicrobial stewardship through health policy;
    • Clinical diagnosis and management of neonatal sepsis;
    • Discharge and transitions of care for birthing parents and newborns.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify the unique risks and burden of sepsis in pregnancy and newborns;
    • Summarize the steps to recognizing sepsis in maternal patients and newborns;
    • Restate how health policies can be used to improve maternal equity and patient outcomes;
    • Summarize the relationship between healthy equity and maternal and neonatal outcomes and sepsis.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Symposium Supporter:

    Sepsis Alliance gratefully acknowledges the support provided for this symposium by Ohio Hospital Association.

    image

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Includes a Live Web Event on 04/30/2024 at 11:00 AM (PDT)

    Content provided by Beckman Coulter (No CE credits offered)

    Webinar Description: 

    In this follow-up to the 2023 webinar, sponsored by Beckman Coulter, take a deeper dive into the CBC test results with a special focus on the white blood cells and differential. Uncover hidden gems and learn about clues pointing to sepsis recognition in order to provide the right care to the right patient at the right time. This sponsored webinar will focus on understanding novel components of the CBC with Diff and the Monocyte Distribution Width (MDW) marker for determining the severity of infection. 

    No CE credits are offered for this Sponsor Innovation Webinar.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Beckman Coulter for this Sponsor Innovation Webinar.

    image

    Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN

    Clinical Nurse Specialist/Consultant

    ADVANCING NURSING, LLC

    Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN, is a critical care clinical nurse specialist and consultant. She has published and lectured nationally and internationally on a variety of pulmonary, critical care, work culture, and sepsis topics, as well as on prevention of health care acquired injuries, including pressure injury and CAUTIs/CLALBSIs and other HAIs. She serves as a subject matter expert on these topics for the American Hospital Association and Michigan Hospital Association. From 1989 to 2003, she functioned in the role of Clinical Nurse Specialist for the Medical ICUs at Henry Ford Hospital in Detroit, Michigan. Currently her company, ADVANCING NURSING LLC, is focused on creating empowered work environments for healthcare practitioners through the acquisition of better skills, attainment of greater knowledge, and implementation of process improvement.

  • Includes a Live Web Event on 04/24/2024 at 11:00 AM (PDT)

    An international task force sponsored by the Society of Critical Care Medicine (SCCM) recently released the new definitions for sepsis and septic shock in children, the Phoenix sepsis criteria. The evolution of pediatric sepsis criteria and the introduction of the Phoenix sepsis criteria will be presented in this webinar.

    Description: 

    Date: April 24, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    Sepsis is a life-threatening condition and globally is one of the leading causes of death in children. An international task force sponsored by the Society of Critical Care Medicine (SCCM) recently released the new definitions for sepsis and septic shock in children, the Phoenix sepsis criteria. The evolution of pediatric sepsis criteria and the introduction of the Phoenix sepsis criteria will be presented in this webinar.

    The research methodology behind the Phoenix criteria for sepsis and septic shock, drawing insights from an extensive international data analysis using machine learning approaches and validation across diverse clinical settings, will also be presented. Attendees will gain valuable insights into the potential implications of implementing the Phoenix sepsis criteria in clinical practice, including its role in facilitating clinical management, quality benchmarking, epidemiological surveillance, and research. 

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Describe the evolution of the pediatric sepsis criteria and the development of the Phoenix sepsis criteria through a three-pronged effort by the SCCM Pediatric Sepsis Definition Task Force;
    • Identify the key differences between the previous pediatric sepsis criteria and the updated Phoenix sepsis criteria;
    • Enumerate the implications of implementing the Phoenix sepsis criteria in clinical practice, including its potential impact on clinical management, quality benchmarking, epidemiological surveillance, and research.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors. 

          

    image

    image

    L. Nelson Sanchez-Pinto, MD, MBI, FAMIA

    Associate Professor, Pediatrics (Critical Care) & Preventive Medicine (Health & Biomedical Informatics)

    Northwestern University – Feinberg School of Medicine

    L. Nelson Sanchez-Pinto, MD, MBI, FAMIA, is a pediatric critical care physician, biomedical informatics specialist, and data science researcher at Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago. His research focuses on applying data science and artificial intelligence approaches to improve the care provided to acutely ill patients, with a particular focus on pediatric sepsis.  

    Lauren Sorce, PhD, APRN-NP, CPNP, AC/PC, FCCM

    Founder's Board Nurse Scientist; Senior Scientist, Division of Pediatric Critical Care; Associate Director of Nursing Research, Department of Nursing

    Ann & Robert H. Lurie Children’s Hospital of Chicago

    Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FAAN, FCCM, is the senior scientist in the Division of Pediatric Critical Care Medicine and Associate Director for Nursing Research in the Department of Nursing at Ann & Robert H. Lurie Children’s Hospital of Chicago, where she also practices as a pediatric critical care nurse practitioner. She is an assistant professor at Northwestern University Feinberg School of Medicine. She trained as a pediatric clinical nurse specialist at Loyola University, followed by a post-masters pediatric nurse practitioner certificate and PhD from Rush University. 

    Dr. Sorce’s key contribution to critical care has been her extensive leadership as an advanced practice registered nurse (APRN). Starting her career as an APRN in the PICU early in the evolution of the role provided her many opportunities. She was instrumental in the exploration of the first acute care pediatric nurse practitioner (ACPNP) certification examination as well as the development of the first national certifying examination for the Pediatric Nursing Certification Board. Dr. Sorce also served as the vice-president of nursing on the board of directors of the World Federation of Pediatric Intensive and Critical Care Societies. She has served in leadership roles on numerous local and international committees as well as participating on editorial boards. 

    Dr. Sorce has served the Society of Critical Care Medicine (SCCM) in many capacities since joining in 1998. Prior to her role on Council, Dr. Sorce was recognized with numerous Presidential Citations, the Norma J. Shoemaker Research Grant, and the Norma J. Shoemaker Award for Nursing Excellence. In addition to nine years on the SCCM Council, she has been a member of the Congress Program Planning Committee and cochaired the 2015 Congress. She chaired the SCCM Strategic Planning Committee, Finance Committee, and Norma J. Shoemaker Research Grant Committee and served as the 2019 editor of SCCM’s newsmagazine, Critical Connections. Dr. Sorce has been funded to study corneal abrasions and has worked on numerous research teams to study post-intensive care syndrome, stress hydrocortisone in pediatric septic shock, prone positioning in pediatric acute respiratory distress syndrome, and criteria for convening family conferences in the PICU.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

    Description

    Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

    Sepsis and the emergence of antimicrobial resistance (AMR) are intricately intertwined and pose significant challenges. Primary reliance on broad-spectrum antimicrobials is often the initial approach in sepsis treatment, yet, curbing unnecessary antimicrobial use is imperative in combating the escalating threat of AMR.

    As AMR intensifies, the likelihood of infections progressing to sepsis increases, rendering sepsis cases progressively more resistant to treatment and consequently subjecting patients to adverse outcomes such as amputations and fatalities. Effectively managing this intricate clinical interplay, addressing the global AMR threat, and enhancing future outcomes necessitate collaborative efforts across sectors, ongoing innovation, and educational initiatives.

    Opportunities for AMR education for clinicians, caregivers, patients, and the public are viewed by 77% of healthcare executives as necessary for combating AMR. Participation in the Sepsis Alliance AMR Conference offers a unique opportunity for attendees to explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.

    Topics covered will include:

    • A One Health approach to combating AMR;
    • Maternal and pediatric AMR;
    • AMR in ambulatory and outpatient settings;
    • The role of Sepsis Teams in AMS.

    Learning Objectives:

    At the conclusion of this event, learners will be able to:

    • Explain the intricate link between sepsis and antimicrobial resistance;
    • Identify tools and resources to champion responsible antimicrobial prescribing practices;
    • Describe the pivotal role of healthcare executives and leadership in prioritizing, endorsing, and advancing stewardship efforts addressing antimicrobial resistance and sepsis;
    • Restate methods for leadership to actively pursue inventive approaches that engage healthcare providers in initiatives aimed at tackling antimicrobial resistance and enhancing sepsis management.

    FREE Nursing CE Credits Offered! 

    Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 9.7 contact hours, Provider Number CEP17068.

    Conference Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:

    image         image           image

    image  
    image      

    Agenda

    April 10, 2024

    Time (ET)Session TitlePresenter
    10:00-10:25Opening Remarks
    10:30-11:05Keynote: AMR and One Health Through the Lens of Animal and Human Health (CE Session)Jason G. Newland, MD, MEd
    Pediatric Infectious Diseases
    Washington University in St. Louis
    Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM
    Executive Director
    National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
    11:10-11:45One Health in Action: Minnesota’s Collaborative Approach to Antibiotic Stewardship (CE Session)Kristen Clark, DVM, MPH, DACVPM, CCRT
    Director, Minnesota One Health Antibiotic Stewardship Collaborative, Minnesota Department of Health
    11:50-12:20 Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and SepsisJames Graham
    Managing Director & Chief Executive Officer, Recce Pharmaceuticals
    12:20-12:30Break
    12:30-1:00Superbugged: A Personal Perspective (CE Session)Steffanie Strathdee, PhD
    Associate Dean of Global Health Sciences, UCSD Department of Medicine
    Thomas Patterson, PhD
    Professor of Psychiatry, University of California, San Diego
    1:05-1:45Antibiotic Stewardship at Hospital Discharge (CE Session)
    Emily Sydnor Spivak, MD, MHS, FIDSA, FSHEA
    Associate Professor of Medicine, Division of Infectious Diseases University of Utah School of Medicine
    1:45-2:15bioMérieux Sponsored Session: Protecting Our Future: Preventing & Treating Sepsis in a World of Drug-Resistant InfectionsAmanda L. Suchanek, Ph.D.
    Medical Advisor, US Medical Affairs
    bioMérieux
    2:15-2:25Break

    2:25-3:00The Epidemiology of Antimicrobial Resistant Bacteria in the Pediatric Population (CE Session) 
    Rachel Medernach, MD, MSCI
    Assistant Professor
    Rush University Medical Center
    3:05-3:45
    CDC Core Elements of Hospital Antibiotic Stewardship and Hospital Sepsis Programs: What Nurses Need to Know and Do (CE Session)
    Mary Lou Manning, PhD, CRNP, CIC, FAPIC, FSHEA, FAAN
    Professor
    Thomas Jefferson University
    3:20-3:35
    Sponsor Session (Details Coming Soon)

    3:45-4:25Antimicrobial Stewardship: Important to All (CE Session)Alyssa R. Letourneau, MD, MPH, FIDSA
    Assistant Professor of Medicine
    Harvard Medical School
    4:25-4:30Closing Remarks

    April 11, 2024

    Time (ET)Session TitlePresenter
    10:00-10:20Opening Remarks: The Value of the Patient Voice and ExperiencesCindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA
    Infection Control Officer and Medical Director of Research
    Jefferson Health – East Region
    Ella Balasa
    Patient Advocate and Sepsis Survivor
    10:25-11:05Keynote: The Global Threat of AMR and Sepsis in the Post-COVID-19 EraUzma Syed, DO
    Infection Disease Specialist
    South Shore Infectious Disease and Travel Medicine Consultants
    11:05-11:25Investigating Racial Disparities Among Patients with Antimicrobial-Resistant InfectionsFelicia Ruffin, PhD, MSN, BSN, BA
    Research Program Leader
    Duke University Medical Center Clinical
    11:30-12:00Sponsor Track 1: BD Sponsored Session: The Vital Role of Blood Culture Quality & Phenotypic ID/AST Results on Sepsis Patient Outcomes
    Masashi Waga
    Technical Director, Clinical Microbiology and Senior Manager, Clinical Microbiology
    12:00 - 12:15Break
    12:15-12:45
    Antibiotic Resistance and Cancer: Challenges and Potential Solutions (CE Session)
    David Greenberg, MD
    Professor of Infectious Diseases and Microbiology, UT Southwestern
    12:50-1:10Current Recommendations from the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) (CE Session)Jason G. Newland, MD, MEd
    Pediatric Infectious Diseases
    Washington University in St. Louis
    Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM
    Executive Director
    National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
    1:15-1:30The Sepsis Alliance AMR C-Suite SurveyAlex Sadorf Colvin
    Director, Marketing and Communications
    Sepsis Alliance
    1:35-1:45Vaults to Staph: Meet Sepsis Survivor Tori KinamonTori Kinamon
    AMR and Sepsis Survivor
    1:45-2:10Break
    2:10-2:35Decolonization to Prevent Serious Infections and Antibiotic Resistant Pathogens: Extending the Benefit to Long-Term Care (CE Session)Susan Huang, MD MPH
    Chancellor’s Professor, University of California Irvine School of Medicine
    2:40-3:15Candida auris: A Global Emerging Multidrug Resistant Pathogen (CE Session)Mahmoud A. Ghannoum, PhD, MBA, FIDSA, FAAM
    Professor, Case Western Reserve University and University Hospitals Cleveland Medical Center
    3:20-3:40The Need for and Approaches to Outpatient Antibiotic Stewardship (CE Session)Rachel Zetts, MPH
    Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
    3:40-4:00Closing RemarksThomas Heymann
    President and CEO
    Sepsis Alliance
  • Recorded On: 03/27/2024

    Content provided by Baxter (No CE credits offered)

    Webinar Description: 

    In this sponsored webinar, Morgan Swearingin, MSN-Ed, RN, CCRN, will discuss the process and experience of creating nurse-driven protocols for SEP-1 interventions and fluid management from the perspective of a bedside nurse and clinical educator. Morgan will explore navigating potential barriers to implementing a successful program. Then, she will conversely highlight breakthroughs and improvements in sepsis care and nursing competence at her institution after implementing nurse-driven protocols and targeted education.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Baxter for this sponsored webinar.

    image


    Morgan Swearingin, MSN-Ed, RN, CCRN

    Critical Care Clinical Education Specialist

    North Kansas City Hospital

    Morgan Swearingin, MSN-Ed, RN, CCRN, is a critical care clinical education specialist at North Kansas City Hospital. Morgan has served in this role for the past 3.5 years, with close to 15 years total of experience in acute care nursing. She graduated in 2009 with an Associate of Science in Nursing (ASN) degree from Hannibal-LaGrange University, and then in 2014 she achieved a Master of Science in Nursing (MSN) degree with an emphasis in Nursing Education from Walden University. Morgan is certified as a critical care registered nurse (CCRN) through the American Association of Critical Care Nurses (AACN), and is notably involved in her local AACN chapter, serving currently as the chapter president of the board of directors. Morgan is passionate about empowering direct care nurses through equipping them with knowledge, competence, and awareness around sepsis identification and management.

  • Recorded On: 03/21/2024

    In the second part of this 2-part series focusing on sepsis education and prevention for school-based healthcare professionals, we'll explore the crucial role of school-based healthcare professionals in recognizing the high risk for sepsis in children, including knowing the key signs and symptoms requiring escalation in care to either a PCP or emergency departments.

    Description: 

    Sepsis affects more than 50 million people worldwide each year, and almost half are children. Although sepsis is the major cause of death within hospitals, up to 87% of sepsis cases originate in the community before patients are admitted. Any number of infections can trigger sepsis in school-aged children. In the second part of this 2-part series focusing on sepsis education and prevention for school-based healthcare professionals, we'll explore the crucial role of school-based healthcare professionals in recognizing the high risk for sepsis in children, including knowing the key signs and symptoms requiring escalation in care to either a PCP or emergency departments. We’ll also cover how to support children who have experienced sepsis. Attendees will learn practical strategies to identify and address time-sensitive clinical deterioration from sepsis, as well as how to best support the lingering effects of post-sepsis syndrome in students, to avoid unnecessary returns to the hospital and potential frequent readmissions.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Distinguish which children may be at highest risk for sepsis and summarize key signs and symptoms indicating clinical deterioration and need for timely escalation in care;
    • List potential lasting affects pediatric sepsis survivors may face post-sepsis;
    • Describe strategies for supporting students and their families during and post-sepsis;
    • Identify educational opportunities for educating students and their families on the importance of early sepsis recognition and treatment.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporter:

    This educational resource is supported by a grant from the Del E. Webb Foundation.

    image

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Fran Balamuth, MD, PhD, MSCE

    Associate Professor of Pediatrics

    University of Pennsylvania

    Fran Balamuth MD, PhD, MSCE, is an Associate Professor of Pediatrics at the University of Pennsylvania and an attending physician in the emergency department at the Children’s Hospital of Philadelphia (CHOP).  Dr. Balamuth’s research interests focus on pediatric sepsis recognition using both epidemiologic and translational approaches, for which she has received both NIH and foundational funding. She is the co-primary investigator of the PROMPT BOLUS trial, a multinational pragmatic trial that compares saline vs. balanced fluids in pediatric sepsis and will be the largest acute care pediatric trial in history. In addition, she co-leads the CHOP Pediatric Sepsis Program, which supports and promotes local clinical, research, educational, and quality improvement initiatives around sepsis. She is an internationally recognized sepsis leader and has been invited to serve on the national steering committee for the Improving Pediatric Sepsis Outcomes quality collaborative through the U.S. Children’s Hospital Association, and three international task forces focused on defining pediatric sepsis through the U.S. Centers for Disease Control and Prevention (CDC), the Surviving Sepsis Campaign, and the Society of Critical Care Medicine.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Through a comprehensive analysis of the epidemiology of pediatric sepsis, attendees will gain valuable insights into the prevalence, risk factors, and clinical implications of this life-threatening condition among children.

    Description: 

    School-based healthcare professionals play a vital role in helping children stay as healthy as possible. They also deal with health issues and emergencies that occur during school hours. In part one of this 2-part series focusing on sepsis education and prevention for school-based healthcare professionals, attendees will explore the critical topic of pediatric sepsis. This presentation will explore the burden of sepsis, particularly focusing on its impact on pediatric populations. Through a comprehensive analysis of the epidemiology of pediatric sepsis, attendees will gain valuable insights into the prevalence, risk factors, and clinical implications of this life-threatening condition among children.

    This session will also highlight the pivotal role of school-based healthcare professionals in supporting sepsis prevention efforts. By emphasizing early recognition strategies, vaccination education initiatives, and the importance of educating families and students about sepsis, attendees will learn practical approaches to enhance sepsis awareness and promote proactive measures within educational settings.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify risk factors of pediatric sepsis;  
    • List ways school-based healthcare professionals can support pediatric sepsis prevention;  
    • Describe how school-based healthcare professionals can educate families and students about infection and sepsis prevention, and the importance of vaccinations.  

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporter:

    This educational resource is supported by a grant from the Del E. Webb Foundation.

    image

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Joseph Carcillo, MD

    Professor of Critical Care Medicine and Pediatrics

    University of Pittsburgh, Department of Critical Care Medicine

    Joseph Carcillo, MD, specializes in pediatric critical care medicine and pediatrics, and is certified by the American Board of Pediatrics. He is affiliated with UPMC Horizon, UPMC Mercy, UPMC Children's Hospital of Pittsburgh, UPMC Altoona, and UPMC Northwest. He completed his medical degree at George Washington University Medical Center, along with a residency and fellowship at Children's National Medical Center. He was previously Taskforce Chair of the ACCM Guidelines for Hemodynamic Support of Newborn and Pediatric Septic Shock, and a member of the Centers for Disease Control and Prevention (CDC) Taskforce for Definitions of Pediatric Sepsis.  

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Live webinar in a "train the trainer" style format about home care responsibilities, infection management, and approaching to maintaining a safe care environment.

    Description: 

    Patients and caregivers play a pivotal role in infection prevention in home care settings. Infusions administered in a home-based setting receive less frequent monitoring by a healthcare professional than those administered in a hospital, putting patients at an increased risk of sepsis and other complications due to infection.  

    In this comprehensive presentation, the presenter will discuss the intricacies of home care, focusing on the distinct roles of patients, caregivers, and healthcare workers in home care. The various types of infections that may arise in a home care setting will be explored, as well as proactive measures to ensure a safe and conducive home care environment. Additionally, the session will provide a review of patient education tools, patient video, and “train the trainer” video available to participants for use and education of their staff, patients, and caregivers. Participants will obtain a comprehensive understanding of home care responsibilities, infection management, and the nuanced approach required to maintain a safe and effective care environment.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify the responsibilities of patients, caregivers, and healthcare workers in home care;
    • Describe types of infections that may occur in home care;
    • Explain the role of patients and caregivers in infection prevention in home care;
    • List warning signs of sepsis in home care;
    • Describe how to balance prevention of antibiotic resistance with management of sepsis in home care.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Supporters:

    Funding for this program was provided in part by an independent educational grant from Pfizer, Inc.

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Sara Keller, MD, MPH, MSPH

    Associate Professor, Division of Infectious Diseases

    Johns Hopkins University School of Medicine

    Sara Keller, MD, MPH, MSPH, is an Associate Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She has joint appointments as Associate Faculty in the Armstrong Institute for Patient Safety, and in the Health Policy and Management Department of the Johns Hopkins University Bloomberg School of Public Health. Her research focuses on expanding healthcare epidemiology and antibiotic stewardship to the outpatient setting, using quantitative and qualitative methods, and applying a human factors engineering framework. She has particularly been recognized for her expertise in improving the quality of care of patients on outpatient parenteral antimicrobial therapy (OPAT), central line-associated bloodstream surveillance and prevention in home infusion therapy, and implementing antibiotic stewardship programs in ambulatory clinics. Her research is funded by the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, and the National Institute on Aging.

    Dr. Keller graduated from Duke University School of Medicine in 2007 and received a Public Health degree with a specialization in epidemiology from the University of North Carolina at Chapel Hill in 2006. She completed her internship and residency in internal medicine at Johns Hopkins University School of Medicine in 2010, then transitioned to the University of Pennsylvania for her infectious diseases training in 2013. She completed a two-year simultaneous fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety, and received a Masters in Health Services Research.

    She also developed and serves as Director of the Patient Safety and Quality Improvement Pathway for Johns Hopkins University School of Medicine Osler Medical Residency Program and directs the Johns Hopkins OPAT Program.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.